Literature DB >> 2037721

Endocrine abnormalities in severe traumatic brain injury--a cue to prognosis in severe craniocerebral trauma?

J M Hackl1, M Gottardis, C Wieser, E Rumpl, C Stadler, S Schwarz, R Monkayo.   

Abstract

Patients with severe craniocerebral trauma (sCCT) display metabolic and endocrine changes. The question is raised whether hormonal patterns give cues to the prognosis of outcome or not. In 21 patients the function of the adrenocortical, gonadal, thyroid and human growth hormone (hGH)-insulin system was assessed. LH, FSH, TSH, prolactin and hGH were stimulated. 3 groups of patients were formed. Group I: patients in acute phase with a Glasgow Coma Score (GCS) more than 6 (group Ia) and less than 6 (group Ib). Group II: patients in transition to traumatic apallic syndrome (TAS). Group III: patients with full-blown or resolving TAS. The values of group Ia comprised low T3, T4 and testosterone, elevated insulin, normal hGH. Group Ib had hypothyroid T3 and T4 and an attenuated response of LH, TSH, prolactin and hGH to stimulation. Group III: there was seen an endocrine normalisation with elevated T4 and TBG and an altered response of hGH and prolactin to stimulation. Endocrine abnormalities were not helpful in predicting which course, either to better or to worse, a given patient would follow.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037721     DOI: 10.1007/bf01708405

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

1.  The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.

Authors:  A P Hansen; S E Christensen; K Lundbaek
Journal:  Scand J Clin Lab Invest       Date:  1975-05       Impact factor: 1.713

2.  Prognostic significance of the changes in the carbohydrate metabolism in severe head injury.

Authors:  T Pentelényi; L Kammerer; F Péter; M Fekete; L Korányi; M Stützel; G Veress; A Bezzegh
Journal:  Acta Neurochir Suppl (Wien)       Date:  1979

3.  Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans.

Authors:  H Shamoon; R Hendler; R S Sherwin
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

4.  Evidence that stimulation of growth hormone release by epinephrine and vasoactive intestinal peptide is based on cell-to-cell communication in the pituitary.

Authors:  M Baes; C Denef
Journal:  Endocrinology       Date:  1987-01       Impact factor: 4.736

5.  Posttraumatic anterior pituitary insufficiency in childhood.

Authors:  H E Gnehm; S Bernasconi; M Zachmann
Journal:  Helv Paediatr Acta       Date:  1979

6.  Can the out come from head injury be improved?

Authors:  T W Langfitt; T A Gennarelli
Journal:  J Neurosurg       Date:  1982-01       Impact factor: 5.115

Review 7.  Nutrition, somatomedins, and the brain.

Authors:  L S Phillips
Journal:  Metabolism       Date:  1986-01       Impact factor: 8.694

8.  Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses.

Authors:  E M Kaptein; D A Grieb; C A Spencer; W S Wheeler; J T Nicoloff
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

9.  [How much reintegration can be achieved in patients after severe craniocerebral injury?].

Authors:  J M Hackl; A Benzer; G Putz; G Mitterschiffthaler; M Prugger; E Rumpl
Journal:  Anaesthesist       Date:  1986-03       Impact factor: 1.041

10.  Functions of central nervous system neurotransmitters in regulation of growth hormone secretion.

Authors:  J B Martin
Journal:  Fed Proc       Date:  1980-09
View more
  16 in total

1.  Endocrine alterations in critically ill patients with stroke during the early recovery period.

Authors:  Ioanna Dimopoulou; Andreas T Kouyialis; Stylianos Orfanos; Apostolos Armaganidis; Marinella Tzanela; Nikolaos Thalassinos; Stylianos Tsagarakis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury.

Authors:  Justin Wagner; Joshua R Dusick; David L McArthur; Pejman Cohan; Christina Wang; Ronald Swerdloff; W John Boscardin; Daniel F Kelly
Journal:  J Neurotrauma       Date:  2010-06       Impact factor: 5.269

Review 3.  Hypothalamic-pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury.

Authors:  Ioanna Dimopoulou; Stylianos Tsagarakis
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

Review 4.  Hypopituitarism and growth hormone deficiency in adult subjects after traumatic brain injury: who and when to test.

Authors:  Monica Lorenzo; Roberto Peino; Ana I Castro; Mary Lage; Vera Popovic; Carlos Dieguez; Felipe F Casanueva
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 5.  Endocrine failure after traumatic brain injury in adults.

Authors:  David J Powner; Cristina Boccalandro; M Serdar Alp; Dennis G Vollmer
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

6.  Stress hormones in accident patients studied before admission to hospital.

Authors:  W Hetz; H D Kamp; U Zimmermann; A von Bohlen; L Wildt; J Schuettler
Journal:  J Accid Emerg Med       Date:  1996-07

Review 7.  A critical review of the pathophysiology of dysautonomia following traumatic brain injury.

Authors:  Ian J Baguley; Roxana E Heriseanu; Ian D Cameron; Melissa T Nott; Shameran Slewa-Younan
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 8.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 9.  The frequency and the diagnosis of pituitary dysfunction after traumatic brain injury.

Authors:  Nigel Glynn; Amar Agha
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

10.  Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: incidence, pattern and predisposing factors.

Authors:  Ioanna Dimopoulou; Stylianos Tsagarakis; Maria Theodorakopoulou; Evangelia Douka; Maria Zervou; Andreas T Kouyialis; Nikolaos Thalassinos; Charis Roussos
Journal:  Intensive Care Med       Date:  2004-04-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.